[图书][B] The evolving epidemiologic and clinical picture of SARS-CoV-2 and COVID-19 disease in children and young people

LM Mofenson, P Idele, D Anthony, J Requejo, D You… - 2020 - unicef.org
The initial impression that paediatric SARS-CoV-2 infection is uncommon and generally mild
has been replaced by a more nuanced understanding of infectious manifestations in …

A review on currently available potential therapeutic options for COVID-19

S Ohadian Moghadam - International Journal of General Medicine, 2020 - Taylor & Francis
A series of unexplained pneumonia cases currently were first reported in December 2019 in
Wuhan, China. Official names have been announced for the virus responsible, previously …

Cancer and immune checkpoint inhibitor treatment in the era of SARS-CoV-2 infection

T Gambichler, J Reuther, CH Scheel, L Susok, P Kern… - Cancers, 2020 - mdpi.com
Simple Summary The introduction of immune checkpoint inhibitors (ICI) in 2011
revolutionized the management of many solid cancers and hematological malignancies …

[HTML][HTML] SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups

GD Liatsos - World Journal of Gastroenterology, 2023 - ncbi.nlm.nih.gov
Liver is unlikely the key organ driving mortality in coronavirus disease 2019 (COVID-19)
however, liver function tests (LFTs) abnormalities are widely observed mostly in moderate …

Cytokine storm in COVID-19: Potential therapeutics for immunomodulation

MM Rana - Journal of Research in Clinical Medicine, 2020 - library.2pressrelease.co.in
The outbreak of new coronavirus disease-20119 or COVID-19 infection has become a
global health emergency at the beginning of this year. Currently, no specific vaccines and …

[PDF][PDF] Reactive hip arthritis and avascular necrosis after severe COVID-19 infection: a case report and comprehensive review of literature

F Alkindi, S Al Nokhatha, K Alseiari, KA Alnaqb - EMJ, 2022 - pdfs.semanticscholar.org
COVID-19 has variable clinical presentations, severity, and multisystem involvement. Some
patients have encountered arthralgia and myalgia symptoms. Reactive arthritis is an …

[HTML][HTML] Pulse therapy with corticosteroids and intravenous immunoglobulin in the management of severe tocilizumab-resistant COVID-19: a report of three clinical …

MV Sheianov, YD Udalov, SS Ochkin, AN Bashkov… - Cureus, 2020 - ncbi.nlm.nih.gov
We present the cases of three patients with severe, life-threatening coronavirus disease
2019 (COVID-19) who had failed to achieve substantial improvement on intial treatment …

Accelerated preclinical paths to support rapid development of COVID-19 therapeutics

JA Grobler, AS Anderson, P Fernandes, MS Diamond… - Cell Host & Microbe, 2020 - cell.com
When SARS-CoV-2 emerged at the end of 2019, no approved therapeutics or vaccines were
available. An urgent need for countermeasures during this crisis challenges the current …

Severe acute respiratory syndrome coronavirus-2 infection and autoimmunity 1 year later: the era of vaccines

A Picchianti Diamanti, MM Rosado, E Nicastri… - Frontiers in …, 2021 - frontiersin.org
Impressive efforts have been made by researchers worldwide in the development of target
vaccines against the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

Management of Severe COVID‐19 in Pregnancy

Y Abourida, H Rebahi, I Oussayeh… - Case Reports in …, 2020 - Wiley Online Library
The scarcity of data concerning pregnant patients gravely infected with severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) makes their management difficult, as …